Sermorelin

FDA Approved

Also known as: GRF 1-29, GHRH(1-29)

What is Sermorelin?

Sermorelin is an FDA-approved growth hormone-releasing hormone (GHRH) analog used to treat growth hormone deficiency in children.

How It Works

Sermorelin stimulates the pituitary gland to produce and release natural growth hormone, maintaining physiological feedback mechanisms.

What Research Shows

Animal Studies

Human Studies

Key Findings:

FDA-approved for pediatric GH deficiency
Stimulates natural GH release patterns
May improve sleep quality and body composition

Dosing Protocol

Typical Dose

200-500 mcg

Frequency

Once daily before bed

Route

Subcutaneous injection

Duration

3-6 months

These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.

Safety & Risks

Reported Side Effects:

Injection site painFlushingHeadacheDizziness

Contraindications:

Active cancer
Pregnancy
Pituitary tumors

Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.

Sourcing & Quality

Quality varies significantly between peptide sources. When sourcing Sermorelin, consider:

Third-party testing (HPLC, Mass Spectrometry)
Certificate of Analysis (CoA) availability
Purity levels (>98% recommended)
Beware of LPS (endotoxin) contamination

CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.

Quick Facts

Track Your Protocol

Use CalcPep to calculate doses, log injections, and track your progress.

Get CalcPep